Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Research results from University of Paris update understanding of cancer
November 5th, 2008
According to recent research from Clichy, France, "Adjuvant treatment could be helpful in prevent recurrence after partial hepatectomy for liver metastases. The purpose of this study was to assess the benefit of in vivo injection of irradiated autologous cancer cells expressing cytokines after partial hepatectomy in rats." "Fifty-four BDIX rats were injected with 3 x 10(6) DHD-K12 cancer cells into the portal vein to induce multiple hepatic metastases. A 70% hepatectomy was carried out 3 days after the injection. The rats were then randomized into three groups of 18 rats each. Rats were given three injections at days 8, 15, and 21 of 5 x 10(6) irradiated DHD-K12 cancer...
Source: Vaccine Weekly (2008-11-05)
|
